Wanbury appoints Prakash Venkatraman as President of API Business
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
EBITDA grew by 31% YoY with EBITDA margin of 11%, a YoY improvement of over 170bps vs. Q1FY24
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
AIIMS Jammu is a beacon of hope not only for the people of J&K, but also for that of Leh, and other neighboring states
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors
Nadda expressed his concern about growing incidence of Non-Communicable Diseases and the importance of awareness regarding healthy diet and lifestyle
Subscribe To Our Newsletter & Stay Updated